| Financial cost of social exclusion: follow up study of antisocial children into adulthood S Scott, M Knapp, J Henderson, B Maughan Bmj 323 (7306), 191, 2001 | 814 | 2001 |
| Resources for mental health: scarcity, inequity, and inefficiency S Saxena, G Thornicroft, M Knapp, H Whiteford The lancet 370 (9590), 878-889, 2007 | 802 | 2007 |
| Cost of disorders of the brain in Europe 2010 A Gustavsson, M Svensson, F Jacobi, C Allgulander, J Alonso, E Beghi, ... European Neuropsychopharmacology 21 (10), 718-779, 2011 | 721 | 2011 |
| Costing psychiatric interventions J Beecham, M Knapp Gaskell, 2001 | 665 | 2001 |
| Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology DS Baldwin, IM Anderson, DJ Nutt, B Bandelow, A Bond, JRT Davidson, ... Journal of Psychopharmacology 19 (6), 567-596, 2005 | 492 | 2005 |
| The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial T Burns, J Catty, T Becker, RE Drake, A Fioritti, M Knapp, C Lauber, ... The Lancet 370 (9593), 1146-1152, 2007 | 476 | 2007 |
| Training carers of stroke patients: randomised controlled trial L Kalra, A Evans, I Perez, A Melbourn, A Patel, M Knapp, N Donaldson Bmj 328 (7448), 1099, 2004 | 389 | 2004 |
| The global costs of schizophrenia. M Knapp, R Mangalore, J Simon Schizophrenia bulletin 30 (2), 279, 2004 | 360 | 2004 |
| The voluntary sector in the United Kingdom J Kendall, M Knapp Manchester University Press, 1996 | 353* | 1996 |
| Evaluation of the individual budgets pilot programme C Glendinning, D Challis, J Fernandez, S Jacobs, K Jones, M Knapp, ... Final Report. York: Social Policy Research Unit, University of York, 2008 | 347 | 2008 |
| Donepezil and memantine for moderate-to-severe Alzheimer's disease R Howard, R McShane, J Lindesay, C Ritchie, A Baldwin, R Barber, ... New England Journal of Medicine 366 (10), 893-903, 2012 | 335 | 2012 |
| Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial A Steventon, M Bardsley, J Billings, J Dixon, H Doll, S Hirani, M Cartwright, ... Bmj 344, e3874, 2012 | 322 | 2012 |
| Dementia UK M Knapp, M Prince, E Albanese, S Banerjee, S Dhanasiri, JL Fernandez, ... London: Alzheimer’s Society 7, 2007 | 302* | 2007 |
| A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. R Churchill, V Hunot, R Corney, M Knapp, H McGuire, A Tylee, S Wessely Health Technology Assessment 5 (35), 1-173, 2002 | 283 | 2002 |
| Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial S Banerjee, J Hellier, M Dewey, R Romeo, C Ballard, R Baldwin, ... The Lancet 378 (9789), 403-411, 2011 | 281 | 2011 |
| Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology SC Smith, DL Lamping, S Banerjee, R Harwood, B Foley, P Smith, ... Health Technology Assessment (Winchester, England) 9 (10), 1-93, 2005 | 275 | 2005 |
| Cost-effectiveness of computerised cognitive–behavioural therapy for anxiety and depression in primary care: randomised controlled trial P McCrone, M Knapp, J Proudfoot, C Ryden, K Cavanagh, DA Shapiro, ... The British Journal of Psychiatry 185 (1), 55-62, 2004 | 275 | 2004 |
| Costs of schizophrenia. M Knapp The British Journal of Psychiatry 171 (6), 509-518, 1997 | 272 | 1997 |
| Poverty and mental disorders: breaking the cycle in low-income and middle-income countries C Lund, M De Silva, S Plagerson, S Cooper, D Chisholm, J Das, M Knapp, ... The Lancet 378 (9801), 1502-1514, 2011 | 268 | 2011 |
| Alternative strategies for stroke care: a prospective randomised controlled trial L Kalra, A Evans, I Perez, M Knapp, N Donaldson, CG Swift The Lancet 356 (9233), 894-899, 2000 | 262 | 2000 |
